InNexus Biotechnology (InNexus Biotechnology) Interest Expense : $-2.08 Mil (TTM As of Mar. 2011)

View and export this data going back to . Start your Free Trial

What is InNexus Biotechnology Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. InNexus Biotechnology's interest expense for the three months ended in Mar. 2011 was $ -0.25 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2011 was $-2.08 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. InNexus Biotechnology's Operating Income for the three months ended in Mar. 2011 was $ -0.32 Mil. InNexus Biotechnology's Interest Expense for the three months ended in Mar. 2011 was $ -0.25 Mil. InNexus Biotechnology did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

InNexus Biotechnology Interest Expense Historical Data

The historical data trend for InNexus Biotechnology's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InNexus Biotechnology Interest Expense Chart

InNexus Biotechnology Annual Data

Trend

Jun01

Jun02

Jun03

Jun04

Jun05

Jun06

Jun07

Jun08

Jun09

Jun10

Interest Expense

Get a 7-Day Free Trial

-0.25

-1.17

-2.69

InNexus Biotechnology Quarterly Data
	Jun06	Sep06	Dec06	Mar07	Jun07	Sep07	Dec07	Mar08	Jun08	Sep08	Dec08	Mar09	Jun09	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11
Interest Expense	Get a 7-Day Free Trial															-0.57	-0.73	-0.60	-0.50	-0.25

InNexus Biotechnology Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2011 adds up the quarterly data reported by the company within the most recent 12 months, which was $-2.08 Mil.

InNexus Biotechnology (GREY:IXSBF) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

InNexus Biotechnology's Interest Expense for the three months ended in Mar. 2011 was $-0.25 Mil. Its Operating Income for the three months ended in Mar. 2011 was $-0.32 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2011 was $0.27 Mil.

InNexus Biotechnology's Interest Coverage for the quarter that ended in Mar. 2011 is calculated as

InNexus Biotechnology did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

InNexus Biotechnology (InNexus Biotechnology) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » InNexus Biotechnology Inc (GREY:IXSBF) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

1055 West Georgia Street, 1500 Royal Centre, Vancouver, BC, CAN, V6E 4N7

Website

http://www.ixsbio.com

InNexus Biotechnology Inc is engaged in commercializing the next generation of monoclonal antibodies based on its DXL technology, which improves the potency of existing antibody products while opening new markets and disease applications.

InNexus Biotechnology (InNexus Biotechnology) Headlines

No Headlines